BAA-GH-OAA-2023 Innovative Health Practices

Background
The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest and collaborate on creating, piloting and scaling innovative research and development interventions utilizing innovative health practices to help reduce disease and mortality rates worldwide. USAID invites organizations and companies to submit an Expression of Interest (EOI) and participate in generating novel tools and approaches that accelerate and sustain improved health outcomes in low-and-middle-income countries (LIMIC). The global community has made great strides in reducing mortality around the world over the last 50 years, but progress in developing countries lags far behind that seen in developed countries. Every year an estimated 303,000 women die during pregnancy and childbirth, 5.9 million children die, and an even greater number become infected with life-threatening diseases like HIV/AIDS, malaria, diarrhea, pneumonia, and tuberculosis, among others. The vast majority of deaths due to these largely preventable causes occur in developing countries where access to health services is often poor. Outbreaks of emerging infectious diseases like Ebola and Zika only serve to further compound these health challenges, taxing already stressed health systems and elevating the risk of disease epidemics of global proportions.

Work Details
The BAA seeks to harness the power of research and development (R&D), innovation, and innovative practices in health, including science, technology, market-based approaches, and financing, to generate new knowledge, tools, and approaches that can reduce LMIC mortality down to the levels seen in high-income countries (HICs). USAID and its partners will work to identify promising R&D approaches that will help to achieve USAID’s goals of preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and combating infectious diseases.

The BAA process involves submission of Expressions of Interest (EOIs) addressing specific criteria related to research or development ideas working towards discovering potential solutions to the Problem and Challenge Statements. Interested parties are required to demonstrate potential significant impact, indicate background and expertise of the organization, outline managerial and technical staff or team engaged in the endeavor, indicate available co-investment resources from submitting organization as well as other third-party businesses, donors, foundations or other organizations.

Stage 2 involves Co-Creation and Co-Development of the Concept Paper where key stakeholders will collaborate on potential solutions based on learnings from the Co-Creation.

Stage 3 includes review by the Peer and Scientific Review Board which will recommend Apparently Successful Partners for moving forward with the project.

Stage 4 involves award determination based on valid innovation to address the Problem/Challenge Statement.

Period of Performance
February 21, 2023 thru February 20, 2028